1. MANUSCRIPT CATEGORIES
HDVR invites the following types of submission:
Reviews
The Journal aims to publish high-quality reviews about topics relating to Dermatology-Venereology, including sexually transmitted diseases, basic and translational research in Dermatology, Interventional and Aesthetic Dermatology, Pediatric Dermatology, Epidemiology, and Guidelines. Reviews may be solicited by the Editor or may be submitted unsolicited by authors for publication. All reviews will be subject to peer review. Reviews must include an unstructured abstract (maximum 300 words), and should not exceed 3500 words of body text and 50 references. Use of illustrations and figures is encouraged.
Original Articles
Original articles are the Journal’s primary mode of communication. Original articles must include a structured abstract (maximum 200 words; see Manuscript requirements), and should not exceed 3000 words of body text and 50 references. If the list exceeds 50 references, an exception is possible: Selected references appear in the print version; the full reference list appears in the English online version.
Manuscripts reporting observational studies must follow STROBE guidelines. Checklists should be uploaded during manuscript submission using file designation ‘Supplementary files for review’.
Manuscripts reporting randomized controlled trials (RCTs) must follow the CONSORT statement. RCTs will not be considered by HDVR without submission of a completed CONSORT checklist. Checklists should be uploaded during manuscript submission using file designation ‘Supplementary files for review’.
Clinical case reports
HDVR publishes Clinical case reports describing interesting patient cases or new therapies for challenging cases. They should be formatted either as a Letter or as a longer article. As a Letter, the manuscript may be formatted in one continuous section and should not exceed 750 words, 10 references and 3 figures/tables. As a longer article, the manuscript will include an Introduction, Case presentation and Discussion presenting a relevant review of the literature, with a word count of up to 2.500 words, 30 references and up to 5 figures/tables.
Viewpoint
These contributions will most often relate to articles published in HDVR within the last 3 months and will be typically commissioned by the Editor-in-chief. However, suggestions for such articles are welcome and should be directed to the Editorial Office. They may include views and assessments of professional, society or scientific topics, which reflect the subjective opinions of experts in the field.
Dermatological Surgery – Tips
This manuscript category contains brief details and tips of surgical or other technical procedures highlight the authors’ personal practice experience. Tips should not exceed 750 words, 3 figures/tables and 10 references.
Editorials / Commentaries
Editorials and commentaries are typically commissioned by the Editors. However, suggestions for such articles are welcome and should be directed to the Editorial Office.
2. SECTIONS
HDVR encourages submission of high-quality manuscripts in all fields of Dermatology-Venereology, with an emphasis on the following sections:
Sexually Transmitted Diseases
Manuscripts may be submitted as original articles, reviews, or clinical case reports. Authors are requested to indicate on the title page and in the cover letter that their contribution is intended for this section.
Basic and translational research in Dermatology
This section covers studies on basic and translational research in all fields of Dermatology-Venereology. Manuscripts may be submitted as original articles or reviews. Authors are requested to indicate on the title page and in the cover letter that their contribution is intended for this section.
Interventional and Aesthetic Dermatology
The section includes studies on Dermatosurgery and Aesthetic Dermatology, including reviews, and original articles. Case reports or small case series are not within the scope of this section. Authors are requested to indicate on the title page and in the cover letter that their contribution is intended for this section.
Epidemiology, Evidence-based Dermatology
This section covers epidemiological studies and articles on evidence-based Dermatology, including original articles and reviews. Authors are requested to indicate on the title page and in the cover letter that their contribution is intended for this section.
Pediatric Dermatology
Manuscripts on Pediatric Dermatology be submitted as original articles, reviews, or clinical case reports. Authors are requested to indicate on the title page and in the cover letter that their contribution is intended for this section.
3. SUBMISSION
Electronic submission
All submissions should be made online through our submission system.
4. MANUSCRIPT PREPARATION
The manuscript can be written in Greek or in English.
The Title, Abstract, author names and affiliations and key words, should be provided both in Greek and in English.
All figures must be supplied electronically (JPEG, TIFF) as separate files and must be numbered. They should not be embedded in the text.
Cover letter
Please include a cover letter declaring that the paper has not been published previously or submitted for publication elsewhere and will not be submitted for publication elsewhere before a decision is reached concerning publication in the HDVR. Please state in the cover letter for which category the manuscript is intended.
Manuscript sequence
Title page: Title, authors with first names, name of institute or clinic, 3-6 key words, in English and in Greek. Details of the corresponding author with postal address, phone and email address. Conflict of interest disclosure for all authors will be mentioned here. All the information in the Title Page will be written in English and in Greek.
Funding: Funding Information including a statement of all funding sources that supported the work should be mentioned in the Title page. If there was no funding, “no funding” should be noted.
Abstract: The abstract should not exceed 200 words, should be easy to understand and not require reference to the text. Abbreviations and references should be avoided in the abstract. The information in the abstract must correspond with that in the text. For original contributions the abstract must be structured. The abstract should be written in both English and in Greek.
Structured abstract: For Original Articles, the summary must have four sections: background and objectives, materials and methods, results, and conclusions. The abstract should be written in both English and in Greek.
Manuscript text: The proper text, structured according to the requirements of the category (Original contributions: introduction, materials and methods, results, discussion) and lists of references, legends of figures and the Tables.
The manuscript text can be written in Greek or in English.
Figures are submitted as separate files.
Legal considerations:
Obtain proper written consent to publish the image if there is any identifiable patient information in the picture. If in doubt, obtain consent. Use of black bars over the eyes of a patient is not adequate to mask the identity of a patient.
Any breach of research or publication ethics including plagiarism, submission of fraudulent results/data, image/data manipulation, and false or incomplete attribution of authorship will be considered malpractice.
References
Please number the references consecutively in the order in which the citations appear in the text. References are cited in the text by inserting the appropriate numbers, which must be superscripted. Each bibliographic entry must have a reference in the text (and vice versa). Format references as below, using standard (Medline) abbreviations for journal titles. If the reference includes 4 authors, all must be named. If there are more than 4 authors in the reference entry, 3 authors must be named and those that follow must be replaced by “et al”.
Reference Examples
1 Author AA, Author BB, Author CC. Title of the paper. Journal 1996; 50: 423-429. (Example: Scarborough D, Bisaccia E, Schven W et al. Anesthesia for the dermatologic surgeon. Int J Dermatol 1989; 28:629-637.)
2 Author DD, Author EE. Title of the book article. In: Editor AA, Editor BB: The Book of Book Articles. 2nd Edition. Place: Publisher, 1996: 423-429. (Example: Goltz R. Paget’s disease, mammary and extra mammary. In: Chun AC, Edelson RL (eds) Malignant tumors of the skin. London: Arnold, 1999: p 294-300.)
Conflicts of Interest
Authors are responsible for disclosing all financial and personal relationships between themselves and others that might be perceived by others as biasing their work. To prevent ambiguity, authors must state explicitly whether potential conflicts do or do not exist. This will be stated in the Title Page.
Ethics
When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 1983. Do not use patients’ names, initials or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate which guidelines on the care and use of laboratory animals were followed. A statement describing explicitly the ethical background of the studies should be included in all manuscripts in the Materials and Methods section.
Ethics committee or institutional review board approval should be stated. Patients have a right to privacy that should not be infringed without informed consent. Identifying information should not be published in written descriptions, photographs or pedigrees unless the information is essential for scientific purposes and the patient (in the alternative parent or guardian) gives written informed consent for publication. Identifying details should be omitted if they are not essential but patient data should never be altered or falsified in an attempt to attain anonymity. Complete anonymity is difficult to achieve and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity.
5. POST-ACCEPTANCE
Copyright licensing
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to complete the license agreement on behalf of all authors on the paper.
Proofs
Page proofs will be sent electronically to the corresponding author and should be returned within 3 days of receipt to the Production Editor. Significant textual alterations are unacceptable at proof stage without the approval of the Editor, and they are likely to result in the delay of publication. The corresponding author will receive an e-mail alert containing a link to a secure web site. A working e-mail address must therefore be provided for the corresponding author. In the absence of the corresponding author, please arrange for a colleague to access the e-mail to retrieve the proofs. Please note that you have final responsibility for what is stated in the proofs of your manuscript. However, the proofs are checked thoroughly by the HDVR editorial team and if we do not receive corrections after two automated reminders to the email address supplied for the corresponding author then we will assume that we have your approval for publication.
6. EDITORIAL POLICY
Authorship
All persons designated as authors should qualify for authorship and all those who qualify should be listed. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of it. One or several authors must take responsibility for the integrity of the work as a whole, from inception to published article. Authorship credit should be based only on 1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content. Conditions 1 and 2 must all be met. All authors must approve of the final version to be submitted. Acquisition of funding, the collection of data or general supervision of the research group, by themselves, do not justify authorship. All others who contributed to the work who are not authors should be named in the Acknowledgments section.
Ethics
When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 1983. Do not use patients’ names, initials or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate which guidelines on the care and use of laboratory animals was followed. A statement describing explicitly the ethical background of the studies should be included in all manuscripts in the Materials and Methods section.
Ethics committee or institutional review board approval should be stated. Patients have a right to privacy that should not be infringed without informed consent. Identifying information should not be published in written descriptions, photographs or pedigrees unless the information is essential for scientific purposes and the patient (in the alternative parent or guardian) gives written informed consent for publication. Identifying details should be omitted if they are not essential but patient data should never be altered or falsified in an attempt to attain anonymity. Complete anonymity is difficult to achieve and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity.
Peer review
HDVR follows a single-blind process of peer review, where the reviewers know who the authors are, but the authors are not aware of the reviewers.
Last update: August 2024